(Total Views: 603)
Posted On: 06/07/2021 4:18:38 PM
Post# of 145248
Article: Ethical Issues Raised Over FDA Collaboration with Biogen on Failed Drug: The FDA collaborated with Biogen to conduct repeated re-analyses of aducanumab for Alzheimer's and FDA committee members are raising concerns.
By: Peter Simons, May 11, 2021
https://www.madinamerica.com/2021/05/ethical-...iled-drug/
(Someone posted this article on ST today).
By: Peter Simons, May 11, 2021
https://www.madinamerica.com/2021/05/ethical-...iled-drug/
(Someone posted this article on ST today).
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)